Literature DB >> 21036824

Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India.

Dhanpat Kumar Kochar1, Gajanand Singh Tanwar, Poonam Chand Khatri, Sanjay Kumar Kochar, Ghanshyam Singh Sengar, Anjana Gupta, Abhishek Kochar, Sheetal Middha, Jyoti Acharya, Vishal Saxena, Deepak Pakalapati, Shilpi Garg, Ashish Das.   

Abstract

Severe Plasmodium vivax malaria in adults has been reported from Bikaner (northwestern India) but the reports on children are scanty. This prospective study was done on 303 admitted children of malaria. The diagnosis was done by peripheral blood smear and rapid diagnostic test. Further confirmation of severe P. vivax monoinfection was done by polymerase chain reaction (PCR). The proportion of P. falciparum, P. vivax, and mixed (P. falciparum and P. vivax) infection was 61.01%, 33.99%, and 4.95%, respectively. Severe disease was present in 49.5% (150/303) children with malaria, with the risk greatest among P. vivax monoinfection (63.1% [65/103]) compared with P. falciparum, either alone (42.7% [79/185]; odds ratio [OR] = 2.3 [95% confidence interval (CI) = 1.40-3.76], P = 0.001) or mixed infections (40% [6/15]; OR = 2.57 [95% CI = 0.88-7.48]). In children < 5 years of age, the proportion of severe malaria attributable to P. vivax rose to 67.4% (31/46) compared with 30.4% (14/46) of P. falciparum (OR = 4.7 [95% CI = 2.6-8.6], P < 0.0001) and 2.2% (1/46) of mixed infection (OR = 92 [95% CI = 24.6-339.9], P < 0.0001). The proportion of patients having severe manifestations, which included severe anemia, thrombocytopenia, cerebral malaria, acute respiratory distress syndrome, hepatic dysfunction, renal dysfunction, abnormal bleeding was significantly high in association with P. vivax monoinfection in 0-5 year age group, while the same was significantly high in association with P. falciparum monoinfection in 5-10 year age group. Similarly P. vivax monoinfection had greatest propensity to cause multiorgan dysfunction in 0-5 year age group (34.1% [17/41], P < 0.0001) in comparison to P. falciparum monoinfection, which had similar propensity in 5-10 year age group (36.8% [35/95], P = 0.039). Plasmodium vivax monoinfection was almost equally serious to cause significant mortality in comparison to P. falciparum (case fatality rate of severe P. vivax was 3.9% versus 3.2% of severe P. falciparum malaria; P = 1.0). This study reaffirms the evidence of severe P. vivax malaria in children in Bikaner.

Entities:  

Mesh:

Year:  2010        PMID: 21036824      PMCID: PMC2963956          DOI: 10.4269/ajtmh.2010.09-0633

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  60 in total

1.  Thrombotic microangiopathy associated with Plasmodium vivax malaria.

Authors:  Sunil Saharan; Utkarsh Kohli; Rakesh Lodha; Alok Sharma; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

2.  Chloroquine resistant vivax malaria in an infant: a report from India.

Authors:  Syed Ahmed Zaki
Journal:  J Vector Borne Dis       Date:  2009-03       Impact factor: 1.688

3.  Chloroquine resistant vivax malaria in an infant: a report from India.

Authors:  Ira Shah
Journal:  J Vector Borne Dis       Date:  2008-06       Impact factor: 1.688

4.  Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua.

Authors:  Mazie J Barcus; Hasan Basri; Helena Picarima; C Manyakori; Iqbal Elyazar; Michael J Bangs; Jason D Maguire; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

5.  Acute lung injury and other serious complications of Plasmodium vivax malaria.

Authors:  Lionel K K Tan; Sophie Yacoub; Sarah Scott; Sanjay Bhagani; Michael Jacobs
Journal:  Lancet Infect Dis       Date:  2008-07       Impact factor: 25.071

6.  Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrocephalus.

Authors:  Rekha Harish; Sanjeev Gupta
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

7.  How benign is benign tertian malaria?

Authors:  Archna Sharma; Uma Khanduri
Journal:  J Vector Borne Dis       Date:  2009-06       Impact factor: 1.688

Review 8.  Neglect of Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Trends Parasitol       Date:  2007-10-22

9.  Childhood cerebral vivax malaria with pancytopenia.

Authors:  Rajoo Thapa; Ramani Ranjan; Vikram S Patra; Subroto Chakrabartty
Journal:  J Pediatr Hematol Oncol       Date:  2009-02       Impact factor: 1.289

10.  Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.

Authors:  Dhanpat K Kochar; Ashish Das; Sanjay K Kochar; Vishal Saxena; Parmendra Sirohi; Shilpi Garg; Abhishek Kochar; Mahesh P Khatri; Vikas Gupta
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

View more
  55 in total

1.  Defying malaria: Fathoming severe Plasmodium vivax disease.

Authors:  Quique Bassat; Pedro L Alonso
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

2.  The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study.

Authors:  Shobha Sharma; Kailash Chandra Aggarwal; Shivani Deswal; Deepak Raut; Neelam Roy; Rohit Kapoor
Journal:  J Clin Diagn Res       Date:  2013-09-10

3.  Benign tertian malaria: how benign is it today?

Authors:  Dinesh Yadav; Jagdish Chandra; Ashok Kumar Dutta
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

4.  New global estimates of malaria deaths.

Authors:  Naman K Shah; Ashwani Kumar; Neena Valecha
Journal:  Lancet       Date:  2012-08-11       Impact factor: 79.321

5.  Type I Interferon Transcriptional Signature in Neutrophils and Low-Density Granulocytes Are Associated with Tissue Damage in Malaria.

Authors:  Douglas Taylor Golenbock; Ricardo Tostes Gazzinelli; Bruno Coelho Rocha; Pedro Elias Marques; Fabiana Maria de Souza Leoratti; Caroline Junqueira; Dhelio Batista Pereira; Lis Ribeiro do Valle Antonelli; Gustavo Batista Menezes
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

Review 6.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

Review 7.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  Development of Visually Improved Loop Mediated Isothermal Amplification for the Diagnosis of Plasmodium vivax Malaria in a Tertiary Hospital in Chandigarh, North India.

Authors:  Hargobinder Kaur; Rakesh Sehgal; Devendra Bansal; Ali A Sultan; Ashish Bhalla; Sunit C Singhi
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

9.  Pattern of malaria in hospitalized children in Khartoum state.

Authors:  Hasan Awadalla Hashim; Eltigani Mohamed Ahmed Ali
Journal:  Sudan J Paediatr       Date:  2017

10.  A comparative study of clinical profiles of vivax and falciparum malaria in children at a tertiary care centre in uttarakhand.

Authors:  Ragini Singh; Shruti Kumar; S K Rana; Brijesh Thakur; S P Singh
Journal:  J Clin Diagn Res       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.